Distinguished Lecture Series - Monday,
May 1, 2006
 Students, Faculty, Staff, and Special Guests are invited to the
H. Wayne Huizenga School of Business and Entrepreneurship Distinguished
Lecture Series featuring: Carl N. Singer, Chairman of Viragen,
Inc. The
event will be held at 10:30 a.m. at the Carl DeSantis Building
in the Julian and Ellen Knight Lecture Hall – Room #1124
on NSU’s Main Campus, 3301 College Avenue, Davie, FL. RSVP
to Lynn Schweitzer at lschweit@nova.edu or (954) 262-5065. (more)
Viragen is a biotechnology company located in Plantation, Florida;
specializing in the research, development, and commercialization
of natural and recombinant protein-based drugs for the treatment
of a broad range of viral and malignant diseases. These protein-based
drugs include Multiferon™, a human natural alpha interferon,
monoclonal antibodies, peptide drugs, and therapeutic vaccines.
Mr. Singer brings vast business experience and accomplishment from
some of America’s largest and leading corporations. Mr.
Singer has served on the Board of Directors for 31 companies including
executive roles as Director, President, and CEO of Sealy, Inc., Scripto,
Inc., and the B.V.D. Company. He currently serves as Chairman
of the Fundamental Management Company in Miami. Mr. Singer’s
commitment and influence have been instrumental in advancing Viragen’s
goals.
|
